Want to use our logo?

Download the ICS Branding Pack

ICS Background

Dr Christopher John Chermansky
Dept of Urology - University of Pittsburgh

ICS 2019

Open Discussion ePoster Session 18 E-Poster 2 320 Sacral Neuromodulation: Determining Predictors of Success

ICS 2018

Podium Short Oral Session 6 Interstitial Cystitis / Bladder Pain Syndrome 1 56 MRI imaging of human bladder wall using intravesical novel contrast mixture: applications in painful bladder syndrome/interstitial cystitis (PBS/IC)

ICS 2017

Podium Short Oral Session 32 Neuromodulation and Intravesical Therapies 547 TWO-YEAR OUTCOMES OF SACRAL NEUROMODULATION VERSUS ONABOTULINUMTOXINA FOR REFRACTORY URGENCY URINARY INCONTINENCE

Open Discussion ePoster Session 35 Open Discussion ePosters 3 644 Electrical Stimulation of Afferent Nerves in the Foot with Transcutaneous Adhesive Pad Electrodes in Women with OAB: Comparison of Different Stimulation Durations

ICS 2016

Open Discussion ePoster Session 7 Open Discussion ePosters 122 MICRORNAS AS POTENTIAL BIOMARKERS TO PREDICT RISK OF URINARY RETENTION FOLLOWING INTRADETRUSOR ONABOTULINUMTOXIN-A INJECTION

ICS 2015

Oral ePoster Session 16 Molecular Mechanisms of Sensation 229 REDUCED AFFERENT SENSITIVITY IN THE RAT BILATERAL PELVIC NERVE CRUSH MODEL OF DETRUSOR UNDERACTIVITY

Podium Short Oral Session 20 New Research in Neuromodulation 259 ELECTRICAL STIMULATION OF SOMATIC AFFERENT NERVES IN THE FOOT IMPROVES OVERACTIVE BLADDER SYMPTOMS

ICS 2012

Non Discussion Poster Session 31 475 Bilateral Pelvic Nerve Crush in the Rat as a Model of Detrusor Underactivity: Reduction of Urethral Sphincter Activity and Isovolumetric Contraction Amplitude

ICS 2011

Non Discussion Poster Session 29 463 Preganglionic Pelvic Nerve Crush Results in Underactive Bladder in the Rat

View Member Details

Christopher Chermansky

Member

Profession:Female Urologist
Qualifications:Professor
Privacy:
You must be logged in to view this contact
Sign-in to ICS

Dr. Chermansky received his medical training at Georgetown University in Washington DC. Dr. Chermansky completed his surgical internship and urology residency at the University of Texas Southwestern in Dallas under the chairmanship of both Dr. Paul C. Peters and Dr. John D. McConnell. After performing postgraduate research with Dr. Emil Tanagho in bladder tissue engineering at the University of California in San Francisco, he completed his fellowship in female urology and neurourology at the University of Pittsburgh with Dr. Michael B. Chancellor. Dr. Chermansky is board certified in FPMRS by the American Board of Urology. He is a member of the American Urological Association and the Society of Urodynamics and Female Pelvic Medicine and Urogenital Reconstruction (SUFU). His practice is concentrated on the evaluation and treatment of voiding dysfunction in both women and men. He also treats patients with neurogenic bladder and female pelvic organ prolapse. An avid researcher, Dr. Chermansky has studied treatments for bladder overactivity and bladder pain. He has published in the area of stem cell therapy as treatment for female stress urinary incontinence. He is also an investigator in the use of Botulinum Toxin A for Overactive Bladder, Also, he is an investigator in the ROSETTA (Refractory Overactive Bladder: Sacral Neuromodulation versus Botulinum Toxin Assessment) Trial within NIH Pelvic Floor Disorders Network.

Dr Christopher John Chermansky declared on the Sunday 2nd April 2017 that they had the following existing or known future financial relationships or affiliations:

Cook Myosite

  • Trial participation
VOLUNTARY (EXPIRED)